Lipidor AB (FRA:L7R) Valuation Rank

View and export this data going back to 2020. Start your Free Trial

What is Lipidor AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Lipidor AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of Lipidor AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipidor AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lipidor AB (FRA:L7R) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

LIPI:Sweden

Address

c/o Ekonomistubben AB, Box 55931, Stockholm, SWE, 102 16

Website

https://www.lipidor.se

Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in the preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections, and atopic dermatitis.